Barriers to influenza vaccination during pregnancy in France: A national population-based study

被引:0
作者
Anselem, Olivia [1 ]
Charlier, Caroline [2 ,3 ]
Viaud, Marie [4 ]
Lelong, Nathalie [4 ]
Vaux, Sophie [4 ,5 ]
Launay, Odile [3 ,6 ]
Le Ray, Camille [1 ,3 ,4 ]
机构
[1] Grp Hosp Paris Ctr, Matern Port Royal, AP HP, FHU Prema, F-75014 Paris, France
[2] Grp Hosp Paris Ctr, Equipe Mobile Infectiol, AP HP, FHU Prema, F-75014 Paris, France
[3] Univ Paris Cite, Paris, France
[4] Univ Paris Cite, Ctr Epidemiol & Stat, Obstetr Perinatal & Pediat Epidemiol Res Team Epop, INSERM UMR 1153, Paris, France
[5] Sante Publ France, St Maurice, France
[6] Inserm, CIC1417, F CRIN 1 REIVAC, AP HP,CIC Cochin Pasteur, Paris, France
关键词
Pregnancy; Vaccination; Immunization; Influenza; Prevention; Information; 2009; H1N1; INFLUENZA; RESPIRATORY ILLNESS; VIRUS INFECTION; WOMEN; IMMUNIZATION; PROTECTION; OUTCOMES;
D O I
10.1016/j.vaccine.2024.126671
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Despite French national recommendations since 2012 that all pregnant women be vaccinated against influenza, in 2021 this vaccine coverage is low - around 30 % - in France. Objectives: To identify barriers to influenza vaccination during pregnancy by assessing how often women were offered this vaccination and how often they accepted it. Study design: We used data from the French national perinatal survey (ENP), which covered all births during one week in March 2021 (N = 12,614). Data came from medical files and face-to-face postpartum interviews. We excluded women who: refused to participate (n = 91), agreed only to complete the minimal questionnaire (n = 435), were not interviewed (N = 1130), or had medical records not mentioning influenza vaccination (N = 120). Factors associated with no offer of influenza vaccination during pregnancy and with refusal of offers that were made were assessed by univariate and multivariate analyses. Results: Among the 10,838 women included, 40.7 % (95 % CI, 39.8-41.6) (n = 4411) reported that they had not been offered this vaccination. This group was younger, (adjusted prevalence ratio (PRa) for women below 25 years was 1.23 (95 % CI, 1.14-1.33)), multiparous more often (PRa 1.37 (95 % CI, 1.27-1.49)), born abroad more often (PRa 1.20, 95 %CI, 1.12-1.29 and less well educated (PRa 1.46 (95 %CI, 1.34-1.58). Among the 6427 women to whom influenza vaccination was offered during pregnancy, 3463 (53.9 %) were not vaccinated. This group was also younger, (PRa 1.23 (95 % CI, 1.14-1.33)), more often multiparous (PRa 1.18; 95 % CI, 1.07-1.30) and had a lower education level (PRa 1.70 (95 % CI, 1.56-1.85)). Conclusion: The low influenza vaccine coverage in France seems mainly related to the failure to offer the vaccine, in particular to those young and less educated. Our study identifies key points of leverage to improve vaccine coverage and reduce the persisting burden of this severe infection.
引用
收藏
页数:9
相关论文
共 43 条
  • [31] santepubliquefrance, Etude de couverture vaccinale contre la grippe chez les professionnels de sante et les residents des Ehpad, saison 2020-2021
  • [32] Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
    Siston, Alicia M.
    Rasmussen, Sonja A.
    Honein, Margaret A.
    Fry, Alicia M.
    Seib, Katherine
    Callaghan, William M.
    Louie, Janice
    Doyle, Timothy J.
    Crockett, Molly
    Lynfield, Ruth
    Moore, Zack
    Wiedeman, Caleb
    Anand, Madhu
    Tabony, Laura
    Nielsen, Carrie F.
    Waller, Kirsten
    Page, Shannon
    Thompson, Jeannie M.
    Avery, Catherine
    Springs, Chasisity Brown
    Jones, Timothy
    Williams, Jennifer L.
    Newsome, Kim
    Finelli, Lyn
    Jamieson, Denise J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (15): : 1517 - 1525
  • [33] SPF, 2022, Point au
  • [34] SPF, 2024, Vaccination en France. Bilan de la couverture vaccinale en 2023
  • [35] Adapting Center for Disease Control and Prevention's immunization quality improvement program to improve maternal vaccination uptake in obstetrics
    Spina, Christine I.
    Brewer, Sarah E.
    Ellingson, Mallory K.
    Chamberlain, Allison T.
    Limaye, Rupali J.
    Orenstein, Walter A.
    Salmon, Daniel A.
    Omer, Saad B.
    O'Leary, Sean T.
    [J]. VACCINE, 2020, 38 (50) : 7963 - 7969
  • [36] Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial
    Steinhoff, Mark C.
    Omer, Saad B.
    Roy, Eliza
    El Arifeen, Shams
    Raqib, Rubhana
    Dodd, Caitlin
    Breiman, Robert F.
    Zaman, K.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (06) : 645 - 653
  • [37] Safety of influenza vaccination during pregnancy
    Tamma, Pranita D.
    Ault, Kevin A.
    del Rio, Carlos
    Steinhoff, Mark C.
    Halsey, Neal A.
    Omer, Saad B.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : 547 - 552
  • [38] Vaccination acceptability in the French general population and related determinants, 2000-2021
    Vaux, Sophie
    Gautier, Arnaud
    Nassany, Oriane
    Bonmarin, Isabelle
    [J]. VACCINE, 2023, 41 (42) : 6281 - 6290
  • [39] Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019
    Vaux, Sophie
    Fonteneau, Laure
    Pefau, Muriel
    Venier, Anne-Gaelle
    Gautier, Arnaud
    Altrach, Sophan Soing
    Parneix, Pierre
    Levy-Bruhl, Daniel
    [J]. VACCINE, 2023, 41 (03) : 812 - 820
  • [40] Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey
    Vaux, Sophie
    Van Cauteren, Dieter
    Guthmann, Jean-Paul
    Le Strat, Yann
    Vaillant, Veronique
    de Valk, Henriette
    Levy-Bruhl, Daniel
    [J]. BMC PUBLIC HEALTH, 2011, 11